Your browser doesn't support javascript.
loading
Twenty-year survival following orthotopic heart transplantation in the United States.
Hess, Nicholas R; Seese, Laura M; Mathier, Michael A; Keebler, Mary E; Hickey, Gavin W; McNamara, Dennis M; Kilic, Arman.
Afiliação
  • Hess NR; Division of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Seese LM; Division of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Mathier MA; Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Keebler ME; Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Hickey GW; Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • McNamara DM; Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Kilic A; Division of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
J Card Surg ; 36(2): 643-650, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33295043
ABSTRACT

BACKGROUND:

This study evaluated 20-year survival after adult orthotopic heart transplantation (OHT).

METHODS:

The United Network of Organ Sharing Registry database was queried to study adult OHT recipients between 1987 and 1998 with over 20-year posttransplant follow-up. The primary and secondary outcomes were 20-year survival and cause of death after OHT, respectively. Multivariable logistic regression was used to identify significant independent predictors of long-term survival, and long-term survival was compared among cohorts stratified by number of predictors using Kaplan Meier survival analysis.

RESULTS:

20,658 patients undergoing OHT were included, with a median follow-up of 9.0 (IQR, 3.2-15.4) years. Kaplan-Meier estimates of 10-, 15-, and 20-year survival were 50.2%, 30.1%, and 17.2%, respectively. Median survival was 10.1 (IQR, 3.9-16.9) years. Increasing recipient age (>65 years), increasing donor age (>40 years), increasing recipient body mass index (>30), black race, ischemic cardiomyopathy, and longer cold ischemic time (>4 h) were adversely associated with a 20-year survival. Of these 6 negative predictors, presence of 0 risk factors had the greatest 10-year (59.7%) and 20-year survival (26.2%), with decreasing survival with additional negative predictors. The most common cause of death in 20-year survivors was renal, liver, and/or multisystem organ failure whereas graft failure more greatly impacted earlier mortality.

CONCLUSIONS:

This study identifies six negative preoperative predictors of 20-year survival with 20-year survival rates exceeding 25% in the absence of these factors. These data highlight the potential for very long-term survival after OHT in patients with end-stage heart failure and may be useful for patient selection and prognostication.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2021 Tipo de documento: Article